• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990-2019 年社区和临床环境中重度抑郁症共病物质使用的流行情况:系统评价和荟萃分析。

Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis.

机构信息

Discipline of Psychiatry and Addiction Medicine, Concord Hospital, University of Sydney, NSW Australia.

Discipline of Psychiatry and CADE Clinic, Royal North Shore Hospital, University of Sydney, NSW Australia.

出版信息

J Affect Disord. 2020 Apr 1;266:288-304. doi: 10.1016/j.jad.2020.01.141. Epub 2020 Jan 26.

DOI:10.1016/j.jad.2020.01.141
PMID:32056890
Abstract

BACKGROUND

Comorbidity between Substance Use Disorders (SUDs) and major depression is highly prevalent. This systematic review and meta-analysis aimed to estimate the prevalence of SUDs in subjects diagnosed with a major depressive disorder (MDD) in community, inpatient and outpatient settings.

METHODS

A comprehensive literature search of Medline, EMBASE, PsycINFO and CINAHL databases was conducted from 1990 to 2019. Prevalence of co-morbid SUDs and MDD were extracted and odds ratios (ORs) were calculated using random effects meta-analysis.

RESULTS

There were 48 articles identified by electronic searches with a total sample size of 348,550 subjects that yielded 14 unique epidemiological studies, 2 national case registry studies, 7 large cohort studies and 20 clinical studies using in- or out-patients. The prevalence of any SUD in individuals with MDD was 0.250. Maximum prevalence was found with alcohol use disorder (0.208), followed by illicit drug use disorder (0.118) and cannabis use disorder (0.117). Meta-analysis showed the pooled variance of any AUD in men with MDD was 36%, which was significantly higher than that for females with MDD (19%, OR 2.628 95% CI 2.502, 2.760).

CONCLUSIONS

Few studies were published over the last decade so current prevalence rates of SUD in MDD are needed. Meta-analysis revealed that SUDs in MDD are highly prevalent and rates have not changed over time. The persistently high prevalence suggests there is an urgent need for more informative studies to help develop better prevention and treatment options for reducing prevalence of SUDs in persons with major depression and co-morbid disorders.

摘要

背景

物质使用障碍(SUDs)与重度抑郁症并存的情况非常普遍。本系统评价和荟萃分析旨在估计社区、住院和门诊环境中诊断为重度抑郁症(MDD)的患者中 SUD 的患病率。

方法

从 1990 年到 2019 年,对 Medline、EMBASE、PsycINFO 和 CINAHL 数据库进行了全面的文献检索。提取合并 SUD 和 MDD 的患病率,并使用随机效应荟萃分析计算比值比(ORs)。

结果

通过电子搜索共确定了 48 篇文章,总样本量为 348550 人,其中有 14 项独特的流行病学研究、2 项国家病例登记研究、7 项大型队列研究和 20 项使用门诊或住院患者的临床研究。MDD 患者中任何 SUD 的患病率为 0.250。最高的患病率见于酒精使用障碍(0.208),其次是非法药物使用障碍(0.118)和大麻使用障碍(0.117)。荟萃分析显示,MDD 男性中任何 AUD 的汇总方差为 36%,显著高于 MDD 女性(19%,OR 2.628 95%CI 2.502, 2.760)。

结论

过去十年中发表的研究较少,因此需要了解目前 MDD 中 SUD 的患病率。荟萃分析显示,MDD 中的 SUD 患病率很高,且患病率随时间没有变化。持续高患病率表明,迫切需要开展更具信息量的研究,以帮助制定更好的预防和治疗方案,降低患有重度抑郁症和合并症患者的 SUD 患病率。

相似文献

1
Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis.1990-2019 年社区和临床环境中重度抑郁症共病物质使用的流行情况:系统评价和荟萃分析。
J Affect Disord. 2020 Apr 1;266:288-304. doi: 10.1016/j.jad.2020.01.141. Epub 2020 Jan 26.
2
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.1990-2017 年社区和临床环境中精神分裂症谱系障碍共病物质使用的流行情况:系统评价和荟萃分析。
Drug Alcohol Depend. 2018 Oct 1;191:234-258. doi: 10.1016/j.drugalcdep.2018.07.011. Epub 2018 Aug 22.
3
Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis.1990 - 2015年临床环境中双相情感障碍与物质使用障碍共病的患病率:系统评价与荟萃分析
J Affect Disord. 2016 Dec;206:331-349. doi: 10.1016/j.jad.2016.07.011. Epub 2016 Jul 9.
4
Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis.1990 - 2014年流行病学调查中合并物质使用、焦虑和情绪障碍的患病率:一项系统评价和荟萃分析
Drug Alcohol Depend. 2015 Sep 1;154:1-13. doi: 10.1016/j.drugalcdep.2015.05.031. Epub 2015 May 28.
5
Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis.1990 - 2015年普通人群全国性调查中双相情感障碍与物质使用障碍的共病情况:系统评价与荟萃分析
J Affect Disord. 2016 Dec;206:321-330. doi: 10.1016/j.jad.2016.06.051. Epub 2016 Jun 25.
6
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.加拿大情绪与焦虑治疗网络(CANMAT)特别工作组关于情绪障碍合并物质使用障碍患者管理的建议。
Ann Clin Psychiatry. 2012 Feb;24(1):38-55.
7
Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.主要抑郁障碍伴或不伴物质使用障碍及物质所致抑郁障碍的差异:来自国家酒精相关条件流行病学调查的结果。
J Clin Psychiatry. 2012 Jun;73(6):865-73. doi: 10.4088/JCP.10m06673. Epub 2012 Mar 20.
8
The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis.神经性厌食症中物质使用障碍和物质使用的患病率:一项系统评价和荟萃分析。
J Eat Disord. 2021 Dec 11;9(1):161. doi: 10.1186/s40337-021-00516-3.
9
Comorbidity of major depression with substance use disorders.重度抑郁症与物质使用障碍的共病情况。
Can J Psychiatry. 2005 Sep;50(10):660-6. doi: 10.1177/070674370505001013.
10
Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.共患大麻使用障碍与重度抑郁症和广泛性焦虑障碍:全国代表性流行病学调查的系统评价与荟萃分析。
J Affect Disord. 2021 Feb 15;281:467-475. doi: 10.1016/j.jad.2020.12.043. Epub 2020 Dec 16.

引用本文的文献

1
Integrated Management of Co-Occurring Alcohol Use Disorder and Depression: Clinical Approaches for Concurrent Disorders.酒精使用障碍与抑郁症共病的综合管理:并发疾病的临床方法
Can J Psychiatry. 2025 Sep 3:7067437251374564. doi: 10.1177/07067437251374564.
2
Sex-stratified genome-wide association meta-analysis of major depressive disorder.重度抑郁症的性别分层全基因组关联荟萃分析。
Nat Commun. 2025 Aug 26;16(1):7960. doi: 10.1038/s41467-025-63236-1.
3
A Post-Hoc Analysis of Depressive Disorders in Patients with Type 2 Diabetes.
2型糖尿病患者抑郁症的事后分析
Healthcare (Basel). 2025 Jul 22;13(15):1773. doi: 10.3390/healthcare13151773.
4
Development of a Sham Smartphone App for Opioid Use Disorder: Acceptability and Suitability Study.用于阿片类物质使用障碍的模拟智能手机应用程序的开发:可接受性和适用性研究。
JMIR Form Res. 2025 Aug 8;9:e71105. doi: 10.2196/71105.
5
Neurobiological Mechanisms of Action of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Substance Use Disorders (SUDs)-A Review.经颅直流电刺激(tDCS)治疗物质使用障碍(SUDs)的神经生物学作用机制——综述
J Clin Med. 2025 Jul 10;14(14):4899. doi: 10.3390/jcm14144899.
6
The inflammation-depression link: How social networks buffer or exacerbate risk.炎症与抑郁的关联:社交网络如何缓冲或加剧风险。
Brain Behav Immun Health. 2025 Jul 4;48:101052. doi: 10.1016/j.bbih.2025.101052. eCollection 2025 Oct.
7
A review of the 257 meta-analyses of the differences between females and males in prevalence and risk, protective factors, and treatment outcomes for mental disorder.对257项关于女性和男性在精神障碍患病率、风险、保护因素及治疗结果方面差异的荟萃分析的综述。
BMC Psychiatry. 2025 Jul 3;25(1):677. doi: 10.1186/s12888-025-06848-7.
8
Provider Perspectives on Medication for AUD in Mental Health and Substance Use Disorder Clinics.心理健康与物质使用障碍诊所中医疗服务提供者对酒精使用障碍药物治疗的看法。
J Dual Diagn. 2025 Jun 13:1-13. doi: 10.1080/15504263.2025.2515026.
9
Sex-stratified genome-wide association meta-analysis of Major Depressive Disorder.重度抑郁症的性别分层全基因组关联荟萃分析。
medRxiv. 2025 May 6:2025.05.05.25326699. doi: 10.1101/2025.05.05.25326699.
10
Neurobiological intersections of stress and substance use disorders.压力与物质使用障碍的神经生物学交叉点。
Front Neurosci. 2025 May 1;19:1548372. doi: 10.3389/fnins.2025.1548372. eCollection 2025.